LIS Technologies Inc. (“LIST” or “the Company”), a proprietary developer of advanced laser technology and the only USA-origin and patented laser uranium enrichment company, today announced that it has received a non-possessing Facility Clearance from the Nuclear Regulatory Commission (NRC). This allows the Company to apply for security clearances for its key employees. The CRISLA technology is a sensitive nuclear technology, and the Company is confident that the DOE will eventually designate the technology as classified restricted data, allowing a path for access to Classified Matter.

Figure 1 – LIS Technologies Inc. Receives a Non-possessing Facility Clearance from the Nuclear Regulatory Commission (NRC) Paving a Path for Access to Classified Matter. This allows the Company to apply for security clearances for its key employees.
“LIS Technologies is positioning itself to become a leader in the production of nuclear fuel for civilian nuclear reactors as well as advanced reactors such as SMRs and microreactors” said Jay Yu, Executive Chairman and President of LIS Technologies Inc. “Obtaining security clearances for key personnel is a major step towards this goal and will enable the Company to accelerate the deployment of our technology.”
“The CRISLA technology shows immense potential, and I believe it is only a matter of time before the DOE Office of Classification requires the technology to be protected,” said Christo Liebenberg, CEO of LIS Technologies Inc. “Our proactive approach in obtaining a Facility Clearance and Q-clearances for key personnel will help to position us favorably once the technology becomes Classified. Several design aspects of the CRISLA technology are already being protected as CUI within the Company.”
LIS Technologies is building on the growing momentum within the United States nuclear energy industry, having been selected in December 2024 as one of six companies to participate in the Low-Enriched Uranium (LEU) Enrichment Acquisition Program. This initiative allocates up to $3.4 billion overall, with contracts lasting for up to 10 years. Optimized for both Low-Enriched Uranium (LEU) and High-Assay Low-Enriched Uranium (HALEU), it overcomes the limitations of traditional pulsed 16µm CO2 lasers, featuring a streamlined design due to its lower absorption and shorter wavelength at 5.3µm. Demonstrated in the 1980s and 90s, this technology is protected by a patent from the United States Patent and Trademark Office (USPTO). Variations of the technology, as well as further development of the baseline technology, is treated by the Company as “Trade Secret” and as such is protected.